AstraZeneca Pharma India Limited

BSE:506820 Stock Report

Market Cap: ₹159.5b

AstraZeneca Pharma India Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Sanjeev Panchal

Chief executive officer

₹38.7m

Total compensation

CEO salary percentage83.4%
CEO tenure1.9yrs
CEO ownershipn/a
Management average tenure1.4yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sanjeev Panchal's remuneration changed compared to AstraZeneca Pharma India's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹819m

Jun 30 2024n/an/a

₹959m

Mar 31 2024₹39m₹32m

₹2b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹2b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹21m₹5m

₹993m

Compensation vs Market: Sanjeev's total compensation ($USD454.21K) is about average for companies of similar size in the Indian market ($USD476.25K).

Compensation vs Earnings: Sanjeev's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Sanjeev Panchal (47 yo)

1.9yrs

Tenure

₹38,725,314

Compensation

Dr. Sanjeev Kumar Panchal serves as Country President of AstraZeneca Pharma India Limited since January 01, 2023 and serves as its Managing Director since January 01, 2023. He serves as Director of AstraZe...

Leadership Team

NamePositionTenureCompensationOwnership
Sanjeev Panchal
MD, Country President & Director1.9yrs₹38.73mno data
Bhavana Agrawal
Whole-Time Director & CFO1.2yrs₹30.59mno data
Pratap Bhuvanagiri
Legal Counsel7.8yrs₹3.73mno data
Manasa R.
Company Secretary & Compliance Officer2.3yrsno datano data
Smita Saha
Vice President of Human Resourcesno data₹12.28mno data
Ayush Agarwal
Interim Business Unit Head of Oncology & Director of Commercial Excellence1.4yrsno datano data
Praveen Akkinepally
Head of Oncology Business Unit1.1yrsno datano data
Vinay Sharma
Business Unit Head - Rare Disease unitless than a yearno datano data
Pankaj Jain
Legal Headno datano datano data

1.4yrs

Average Tenure

Experienced Management: 506820's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Sanjeev Panchal
MD, Country President & Director1.9yrs₹38.73mno data
Bhavana Agrawal
Whole-Time Director & CFOless than a year₹30.59mno data
Revathy Ashok
Independent Non-Executive Director8yrs₹1.20mno data
Monica Widhani
Additional Independent Directorless than a yearno datano data
Hooi Chuah
Additional Non-Executive Director1.1yrsno datano data
Nirula Shilpa Divekar
Independent Non-Executive Chairperson of the Board3yrs₹1.30mno data
Sylvia Lorena Ramon
Non-Executive Directorless than a yearno datano data
Jesus Javier Diaz Esteso
Additional Non-Executive Directorless than a yearno datano data

1.0yrs

Average Tenure

58yo

Average Age

Experienced Board: 506820's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 20:03
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AstraZeneca Pharma India Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research